This brand name is authorized in Mexico, United States, South Africa
The drug ACCOLATE contains one active pharmaceutical ingredient (API):
UNII XZ629S5L50 - ZAFIRLUKAST
Zafirlukast is a selective and competitive receptor antagonist of leukotriene D4 and E4 (LTD4 and LTE4), components of slowreacting substance of anaphylaxis (SRSA). Cysteinyl leukotriene production and receptor occupation have been correlated with the pathophysiology of asthma, including airway edema, smooth muscle constriction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.
Below package inserts are available for further reading:
|ACCOLATE Coated tablet
|FDA, National Drug Code (US)
|MPI, US: SPL/Old
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
|R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DC Leukotriene receptor antagonists
This drug has been assigned below unique identifiers within the countries it is being marketed:
|Comisión Federal para la Protección contra Riesgos Sanitarios
|FDA, National Drug Code
|Identifier(s): 49884-589, 49884-590
|Health Products Regulatory Authority
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.